Prognostic Value of Day 3 Inhibin-B on Assisted Reproductive Technology Outcome

보조 생식술 결과에 있어서 기저혈중 Inhibin-B의 예후인자로서의 유용성

  • Bai, Sang-Wook (Department of Obstetrics & Gynecology, College of Medicine, Yonsei University) ;
  • Kim, Jin-Young (Department of Obstetrics & Gynecology, College of Medicine, Yonsei University) ;
  • Lee, Kyung-Sool (Department of Obstetrics & Gynecology, College of Medicine, Yonsei University) ;
  • Won, Jong-Gun (Department of Obstetrics & Gynecology, College of Medicine, Yonsei University) ;
  • Lee, Yong-Joo (Department of Obstetrics & Gynecology, College of Medicine, Yonsei University) ;
  • Yi, Ji-Won (Department of Obstetrics & Gynecology, College of Medicine, Yonsei University) ;
  • Chang, Kyung-Hwan (Department of Obstetrics & Gynecology, College of Medicine, Yonsei University) ;
  • Lee, Byung-Seok (Department of Obstetrics & Gynecology, College of Medicine, Yonsei University) ;
  • Park, Ki-Hyun (Department of Obstetrics & Gynecology, College of Medicine, Yonsei University) ;
  • Cho, Dong-Jae (Department of Obstetrics & Gynecology, College of Medicine, Yonsei University) ;
  • Song, Chan-Ho (Department of Obstetrics & Gynecology, College of Medicine, Yonsei University)
  • 배상욱 (연세대학교 의과대학 산부인과학교실) ;
  • 김진영 (연세대학교 의과대학 산부인과학교실) ;
  • 이경술 (연세대학교 의과대학 산부인과학교실) ;
  • 원종건 (연세대학교 의과대학 산부인과학교실) ;
  • 이용주 (연세대학교 의과대학 산부인과학교실) ;
  • 이지원 (연세대학교 의과대학 산부인과학교실) ;
  • 장경환 (연세대학교 의과대학 산부인과학교실) ;
  • 이병석 (연세대학교 의과대학 산부인과학교실) ;
  • 박기현 (연세대학교 의과대학 산부인과학교실) ;
  • 조동제 (연세대학교 의과대학 산부인과학교실) ;
  • 송찬호 (연세대학교 의과대학 산부인과학교실)
  • Published : 1997.08.30

Abstract

This study was performed to determine if women with day 3 serum inhibin-B concentrations <45pg/ml (conversion factor to SI unit, 1.00) demonstrate a poor response to ovulation induction and assisted reproductive technology outcome to women with inhibin-B${\ge}45pg$/ml, independant of day 3 FSH, E2 and patient age. From Jan 1996 to Dec 1996, 16 volunteers patients who underwent 25 IVF cycles with luteal phase GnRH agonist suppression and HMG stimulation were allocated to the study group. We evaluated day 3 serum inhibin-B, FSH, E2, peak E2, cancellation rate per initiated cycle (%) and clinical pregnancy rate per initiated cycle (%) according to the above two groups and independent of patient age, day 3 FSH, day 3 E2 and all of above combined. Women with day 3 serum inhibin-B${\ge}45pg$/ml demonstrated higher average day 3 inhibin-B level, clinical pregnancy rate per initiated cycle ($20.3{\pm}2.5$ pg/ml vs $80.9{\pm}5.0$ pg/ml, p<0.05; 24.8% vs 8.5%, p<0.05) and lower day 3 FSH level, cancellation rate per initiated cycle ($6.9{\pm}0.3$ mIU/ml vs $8.5{\pm}0.5$ mIU/ml, p<0.05; 1.5% vs 9.0%, p<0.05). Women with day 3 serum inhibin${\ge}45pg$/ml and age<40 year demonstrated higher pregnancy rate per initiated cycle (28.2% vs 7.4%, p<0.05) and lows. day 3 FSH level, cancellation rate per initiated cycle ($6.9{\pm}0.5$ mIU/ml vs $8.2{\pm}0.7$ mIU/ml, p<0.05; 1.0% vs 9.0%, p<0.05). Women with day 3 serum inhibin${\ge}45pg$/ml and day 3 FSH<15mIU/ml demonstrated higher pregnancy rate per initiated cycle (33.5% vs 9.5%, p<0.05) and lower day 3 FSH level, cancellation rate per initiated cycle ($7.7{\pm}0.2$ mIU/ml vs $8.5{\pm}0.5$ mIU/ml, p<0.05; 1.5% vs 10.0%, p<0.05). Women with day 3 serum inhibin${\ge}45pg$/ml and day 3 E2<50pg/ml demonstrated higher pregnancy rate per initiated cycle (30.0% vs 9.5%, p<0.05) and lower cancellation rate per initiated cycle (1.5% vs 9.5%, p<0.05). Women with day 3 serum inhibin${\ge}45pg$/ml, age<40 year, day 3 FSH<15mIU/ml and day 3 E2<50pg/ml demonstrated higher pregnancy rate per initiated cycle (30.0% vs 10.8%, p<0.05) and lower day 3 FSH level, cancellation rate per initiated cycle ($6.8{\pm}0.6$ mIU/ml vs $8.4{\pm}0.9$ mIU/ml, p<0.05; 1.5% vs 7.8%, p<0.05). Therefore women with low day 3 serum inhibin-B concentrations demonstrate a poorer response to ovulation induction and are less likely to conceive a clinical pregnancy though ART relative to women with high day 3 inhibin-B and day 3 serum inhibin-B, in addition to a day 3 FSH, E2 and patient age, appears helpful in prediction in IVF-ET outcome.

Keywords